Exogenus Therapeutics is one of the five companies presenting projects in the Innocore Challenge. The initiative is part of the project “InnoCore – Core Technologies for Education and Innovation in Life Sciences”, funded by the Erasmus+ programme, and combines training in Advanced Technologies in Life Sciences with education to Innovation & Entrepreneurship.